Follow-Up of Bladder Cancer Patients From the New England Study of Environment and Health
Completed
Conditions studied: Bladder Cancer
In brief
Background: * Bladder cancer often recurs after treatment and patient survival varies greatly. * More knowledge is needed about factors that can help identify patients who are at greater risk of disease recurrence and progression to minimize the need for screening and to help guide treatment. * The New England Study of Environment and Health (NESEH), conducted by the departments of health in Maine, New Hampshire and Vermont, the Dartmouth Medical School and the NIH, examined the relationship between health and environmental factors such as smoking, diet and water quality in New England. This study provides an opportunity to learn more about patients with bladder cancer. * Before launching a full-scale follow-up study on bladder cancer, it is necessary to determine the feasibility of obtaining needed follow-up information from patients enrolled in the NESEH. Objectives: -To determine the completeness and quality of information about treatment, recurrence, and progression that can be obtained for patients from their medical records. Eligibility: -Participants from the NESEH study who are residents of Maine and who were diagnosed with bladder cancer between 2001 and 2003. Design: * Determine the vital status of NESEH bladder cancer patients. * Select a sample of 40 living and 18 deceased patients. * Interview patients or their next of kin by telephone for about 30 to 45 minutes to update exposure information, obtain names and addresses of all hospitals and physicians they have seen since diagnosis, and obtain authorization to access medical records. * Obtain and abstract medical records.
Key facts
- Study ID
- NCT00776178
- Run by
- National Cancer Institute (NCI)
- People needed
- 68
- Starts
- 2008-10-17
- Expected to finish
- 2020-03-31
- Last updated by the study team
- 2020-04-07
Who can join
Age: 30 and older, up to 79. Sex: any. Healthy volunteers: not accepted.
You may not qualify if…
- We will exclude from the feasibility study the following NESEH case participants:
- 44 bladder cancer patients (7 percent) first diagnosed at one of seven hospitals located in remote areas of ME (Aroostook Medical Center, Calais Regional Hospital, Cary Medical Center, Down East Community Hospital, Houlton Regional Hospital, Northern Maine Medical Center, and Mount Desert Hospital); this is for cost considerations;
- Patients diagnosed fewer than 5 years before the feasibility study begins (i.e., after 2003)
Where it is running
- National Cancer Institute (NCI), 9000 Rockville Pike — Bethesda, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.